Metraipolis › archive › dc_ea085922fbf3

CLEC4G Reverses Lenvatinib Resistance in Hepatocellular Carcinoma by Suppressing PD-1 Expression via the Wnt/β-Catenin Pathway — Europe PMC PMID:41395114

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41395114
DOI
10.1155/ijog/9225945
License (as archived)
solo-consultazione
Archived
2026-11-07T17:32:38.132Z
SHA-256 of the archived text
b7015ed31a63f919a31e59922e74ab5cb12d51bb83db30f2a1ac8b894e47c0c0
Stable URL of this page
https://metraipolis.com/documento/dc_ea085922fbf3

How to cite

CLEC4G Reverses Lenvatinib Resistance in Hepatocellular Carcinoma by Suppressing PD-1 Expression via the Wnt/β-Catenin Pathway — Europe PMC PMID:41395114 — Europe PMC (en), https://europepmc.org/article/MED/41395114 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ea085922fbf3 (Metraipolis archive dc_ea085922fbf3, sha256 b7015ed31a63f919a31e59922e74ab5cb12d51bb83db30f2a1ac8b894e47c0c0)
BibTeX
@misc{dcea085922fbf3,
  title = {CLEC4G Reverses Lenvatinib Resistance in Hepatocellular Carcinoma by Suppressing PD-1 Expression via the Wnt/β-Catenin Pathway — Europe PMC PMID:41395114},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41395114},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ea085922fbf3; sha256 b7015ed31a63f919a31e59922e74ab5cb12d51bb83db30f2a1ac8b894e47c0c0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41395114. Agents can read the archived copy with the MCP tool read_document.